Gocovri 68.5 mg is a prescription medication approved for the treatment of relapsing‑remitting multiple sclerosis (RRMS). It’s a fixed‑dose combination product that contains two active ingredients:
| Component |
Strength |
Dose‑form |
Function |
| Interferon‑β‑1a |
54 µg |
Subcutaneous (SC) injection |
Modulates the immune system to reduce inflammation and demyelination in the central nervous system. |
| Teriflunomide |
14.5 mg |
Oral tablet |
Inhibits dihydroorotate dehydrogenase, thereby limiting proliferation of activated T‑ and B‑lymphocytes. |
The total daily dose is 68.5 mg (54 µg IFN‑β‑1a + 14.5 mg teriflunomide). It’s taken once daily by mouth. The interferon component is injected subcutaneously on the first day of each dosing week, and the oral teriflunomide is taken the next day (or on a different day of the week if you prefer). The two drugs are formulated so that the interferon’s effects last until the next injection, while the oral tablet maintains the anti‑proliferative effect.
How to Use Gocovri
-
Injection (IFN‑β‑1a)
- Use a new, sterile needle and syringe for each injection.
- Inject into the thigh, abdomen, or upper arm (avoid the same site consecutively).
- Inject at the same time each week (e.g., morning or evening).
-
Oral Tablet (Teriflunomide)
- Take the tablet with water, preferably at the same time each day.
- Do not split or chew the tablet.
-
Timing
- Typically, the injection is on Day 1 of the week, the tablet on Day 2, and then the next injection on Day 8.
- If you miss a dose, take it as soon as possible but skip the missed tablet if you’re close to the next dose (follow your prescriber’s specific instructions).
-
Missed Dose
- If you miss the oral dose, take it as soon as you remember.
- If you miss the injection, do not double‑dose. Instead, take the next dose at the usual time.
What It’s For
- Reduces the frequency and severity of relapses in RRMS.
- Slows the progression of disability compared to placebo.
- Has been shown to decrease MRI activity (new or enlarging lesions).
Common Side Effects
| Category |
Examples |
| Injection site reactions |
Pain, redness, swelling, induration |
| Flu‑like symptoms |
Fever, chills, muscle aches, fatigue |
| Headache |
Mild to moderate |
| Nausea/diarrhea |
Less common with teriflunomide |
| Liver enzyme elevations |
Monitor via blood tests |
| Hair thinning |
Rare |
Most side effects are mild to moderate and often improve after the first few weeks of therapy. Report persistent or severe reactions to your clinician.
Important Safety Information
| Area |
Details |
| Contraindications |
Known hypersensitivity to either component, active hepatitis B, untreated hepatitis C, severe hepatic impairment, pregnancy (teriflunomide is teratogenic). |
| Pregnancy & Breastfeeding |
Avoid use if pregnant or planning pregnancy. Teriflunomide can cause fetal harm; a contraception plan is essential. Breastfeeding is not recommended. |
| Drug Interactions |
• CYP3A4 inhibitors (e.g., ketoconazole) can raise teriflunomide levels.
• CYP3A4 inducers (e.g., rifampin) may lower teriflunomide levels.
• Immunosuppressants (e.g., methotrexate, azathioprine) may increase infection risk. |
| Liver Monitoring |
Check ALT, AST, ALP, bilirubin before starting, every 4–8 weeks for the first 6 months, then every 6–12 months. |
| Infusion Reactions |
Not applicable—this is an injection, not an IV infusion. |
| Vaccinations |
Live vaccines are generally contraindicated while on teriflunomide. Inactivated vaccines are safe. |
Storage
- Injection: Store at 2–8 °C (refrigerated). Do not freeze. Use within 24 h after reconstitution.
- Oral Tablet: Store at room temperature (15–30 °C). Keep out of reach of children.
What to Watch For
- Signs of infection (fever, chills, sore throat).
- Unexplained weight loss, fatigue, or hair loss.
- Liver‑related symptoms (jaundice, dark urine).
- Mood changes (depression, anxiety).
If you notice any of these, contact your healthcare provider promptly.
Quick FAQ
Q: Can I take Gocovri with other MS drugs?
A: Some combination regimens exist (e.g., teriflunomide with dimethyl fumarate), but combining with other disease‑modifying therapies can increase side‑effect risk. Always discuss with your neurologist.
Q: What if I miss my injection?
A: If it’s been less than 5 days since the missed dose, skip the injection and resume the next week. If more than 5 days, take the next dose at the regular time.
Q: Is there a special diet?
A: No special diet is required, but a balanced diet can help mitigate flu‑like symptoms.
Q: How long will I be on this medication?
A: Duration varies; many patients continue for years. Regular MRI and clinical reviews guide ongoing therapy.
Bottom Line
Gocovri 68.5 mg offers a convenient once‑daily oral and weekly injectable regimen that targets two distinct pathways in RRMS, making it a potent option for many patients. If you have specific questions about dosing schedules, side‑effect management, or interactions with other medications you’re taking, let me know—I’m happy to dive deeper!